Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T20:15:46.398Z Has data issue: false hasContentIssue false

Antiepileptic effects of quinine in the pentylenetetrazole model of seizure

Published online by Cambridge University Press:  16 April 2020

B. Torabinejad
Affiliation:
Qazvin University of Medical Sciences, Qazvin, Iran
M. Nassiri-Asl
Affiliation:
Pharmacology, Qazvin, Iran
F. Zamansoltani
Affiliation:
Anatomy, Qazvin University of Medical Sciences, Qazvin, Iran

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Quinine, is an anti-malarial drug that specifically blocks connexin 36 at gap junction channels.

Objective

Quinine has suppressed ictal epileptiform activity in vitro without decreasing neuronal excitability.

Aim

We considered the possible anticonvulsant effects of quinine in the pentylenetetrazole (PTZ) model of seizure.

Methods

In five groups, the mice were given quinine at the doses of 20, 30, 40, 50, or 60 mg/kg 30 min before the administration of PTZ (90 mg/kg). Two groups were injected with diazepam, the positive control (0.5, 1 mg/kg) and one group, the control group, was injected with saline + Tween 80 before the administration of PTZ. The onset of a general clonus was used as the endpoint. The general clonus was characterized by forelimb clonus followed by full clonus of the body.

Results

In the PTZ model, quinine at the dose of 60 mg/kg increased the latency of seizure. However, quinine at 40-60 mg/kg decreased the duration of seizure, dose dependently.

Conclusion

The present study provides evidence for anticonvulsant activity of quinine in the generalized clonic seizure of PTZ model. As a result of these finding, we suggest that gap junctions represent an appropriate target for the development of drugs aimed at decreasing epileptiform synchronization and preventing epileptogenesis.

Type
P03-117
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.